HBV/HCV/HIV serology mandatory pre-rituximab; no NMZL-specific infectious driver establis...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-NMZL-INFECTION-SCREENING |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-NODAL-MZL |
| Sources | SRC-ESMO-MZL-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | HBV/HCV/HIV serology mandatory pre-rituximab; no NMZL-specific infectious driver established (unlike HCV-MZL or H. pylori gastric MALT). |
|---|---|
| Clinical direction | investigate |
| Category | infection-screening |
Trigger Logic
{
"any_of": [
{
"finding": "hbsag",
"value": "positive"
},
{
"finding": "anti_hcv",
"value": "positive"
},
{
"finding": "hiv_serology",
"value": "positive"
}
],
"type": "biomarker"
}
Notes
Cross-disease HBV reactivation risk handled by RF-UNIVERSAL-HBV-REACTIVATION-RISK; this disease-specific entry kept for NMZL MDT-brief annotation.
Used By
Algorithms
ALGO-NMZL-1L- ALGO-NMZL-1L